Kiora Pharmaceuticals Inc. (KPRX)
Market Open
11 Sep, 13:35
NASDAQ (CM) NASDAQ (CM) Primary $
2. 60
+0.02
+0.7752%
$
11.3M Market Cap
0.69 P/E Ratio
- Div Yield
133 Volume
-1.74 Eps
$ 2.58
Previous Close 
Want to track KPRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kiora Pharmaceuticals Inc. (KPRX) Statistics
Valuation metrics
Market Cap 11.3M
Enterprise value 4.56M
Trailing P/E (ttm) -1.02
Forward P/E -1.16
PEG ratio -0.05
Price/Sales (ttm) 0.48
Price/Book (mrq) 0.93
Enterprise Value/Revenue -0.71
Enterprise Value/EBITDA -0.37
Overview
Shares outstanding 3.76M
Float 4.3M
Shares short 30.79K
% Held by insiders 0.03%
% Held by institutions 0.16%
Average volume (10 days) 4.5K
Average volume (90 days) 19.32K
Price summary
52-Week low 1.76
52-Week high 2.95
Beta -0.77
50-Day moving average 2.58
200-Day moving average 2.34
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 11 Jun 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin 0.36%
Operational effectiveness
Return on assets -0.46%
Return on equity -0.63%
Income Statement
Revenue (ttm) 16M
Revenue per share (ttm) 4.13
Quarterly revenue growth (yoy) -
Gross profit (ttm) -3.71M
EBITDA -9.87M
Net income to common (ttm) -11.06M
Diluted EPS (ttm) -1.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 13.87M
Total cash per share (mrq) 2.73
Total debt (mrq) 373.59K
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 8.97%
Book value per share (mrq) 2.73
Cash Flow
Cash flow statement -10.42M
Levered free cash flow (LFCF) -9.58M
